July 2015 FDA Recall Drug by Apotex Inc.
D1834-2015 - Failed Dissolution Specification

This Class III drug recall was voluntarily initiated by Apotex Inc. on July 21, 2015 for the product Drug. The FDA reported the reason for recall as failed dissolution specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D1834-2015

Reason for Recall
Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.
Initiated
07-21-2015
Reported
10-07-2015
Quantity
2,075 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nationwide and Puerto Rico
Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.

Batch or Lot Expiration Information

Lot# : KP2621, Exp 8/2015